Immix Biopharma (IMMX) Change in Taxes (2021 - 2026)
Quarterly results put Change in Taxes at $725.0 for Q1 2026, up 100.04% from a year ago — trailing twelve months through Mar 2026 was -$55202.0 (up 97.16% YoY), and the annual figure for FY2025 was -$2.1 million, down 311.99%.
Immix Biopharma has reported Change in Taxes over the past 6 years, most recently at $725.0 for Q1 2026.
- Change in Taxes reached $725.0 in Q1 2026 per IMMX's latest filing, up from -$12379.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $911540.0 in Q1 2024 and bottomed at -$2.0 million in Q1 2025.
- Median Change in Taxes over the past 5 years was $29258.0 (2022), compared with a mean of $2501.8.
- The largest annual shift saw Change in Taxes surged 1199.6% in 2023 before it plummeted 319.8% in 2025.
- Over 5 years, Change in Taxes stood at $60949.0 in 2022, then surged by 664.45% to $465925.0 in 2023, then plummeted by 51.76% to $224779.0 in 2024, then crashed by 105.51% to -$12379.0 in 2025, then soared by 105.86% to $725.0 in 2026.
- Business Quant data shows Change in Taxes for IMMX at $725.0 in Q1 2026, -$12379.0 in Q4 2025, and -$21564.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 725.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 725.00 |
| Mar 31, 2026 | 725.00 |
| Dec 31, 2025 | -12,379.00 |
| Dec 31, 2025 | -12,379.00 |
| Sep 30, 2025 | -21,564.00 |
| Sep 30, 2025 | -21,564.00 |
| Jun 30, 2025 | -21,984.00 |
| Jun 30, 2025 | -21,984.00 |
| Mar 31, 2025 | -2.00 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | 224,779.00 |
| Dec 31, 2024 | 224,779.00 |
| Sep 30, 2024 | -68,542.00 |
| Sep 30, 2024 | -68,542.00 |
| Jun 30, 2024 | -96,250.00 |
| Jun 30, 2024 | -96,250.00 |
| Mar 31, 2024 | 911,540.00 |
| Mar 31, 2024 | 911,540.00 |
| Dec 31, 2023 | 465,925.00 |
| Dec 31, 2023 | 465,925.00 |
| Sep 30, 2023 | 380,237.00 |
| Sep 30, 2023 | 380,237.00 |
| Jun 30, 2023 | -24,949.00 |
| Jun 30, 2023 | -24,949.00 |
| Mar 31, 2023 | 72,188.00 |
| Mar 31, 2023 | 72,188.00 |
| Dec 31, 2022 | 60,949.00 |
| Dec 31, 2022 | 60,949.00 |
| Sep 30, 2022 | 29,258.00 |
| Sep 30, 2022 | 29,258.00 |
| Jun 30, 2022 | 110,217.00 |
| Jun 30, 2022 | 110,217.00 |
| Mar 31, 2022 | 35,960.00 |
| Mar 31, 2022 | 35,960.00 |
| Dec 31, 2021 | -170,596.00 |
| Dec 31, 2021 | -170,596.00 |
| Sep 30, 2021 | 21,293.00 |
| Sep 30, 2021 | 21,293.00 |
| Jun 30, 2021 | 26,143.00 |
| Jun 30, 2021 | 26,143.00 |
| Mar 31, 2021 | 25,493.00 |
| Mar 31, 2021 | 25,493.00 |